Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Comparative Study Between Rectal and Intrauterine Misoprostol Administration in the Reduction of Blood Loss During and After Elective Cesarean Delivery in Low Risk Women
Sponsor: Cairo University
Summary
One hundred forty low risk pregnant women scheduled for elective cesarean delivery were randomized (1:1) into two groups: the intrauterine group (n=70) received 400 μg misoprostol (200 μg at each uterine cornu) after placental delivery, while the rectal group (n=70) received 400 μg misoprostol rectally via urinary catheter insertion preoperatively.
Official title: A Comparative Study Between Rectal and Intrauterine Misoprostol Administration in the Reduction of Blood Loss During and After Elective Cesarean Delivery in Low Risk Women: A Randomized Controlled Trial
Key Details
Gender
FEMALE
Age Range
20 Years - 40 Years
Study Type
INTERVENTIONAL
Enrollment
140
Start Date
2025-01-13
Completion Date
2026-06-29
Last Updated
2026-07-27
Healthy Volunteers
No
Conditions
Interventions
Misoprostol Tabets
400 μg of misoprostol administered intrauterinely after placental delivery during cesarean section
Misoprostol Tabets
400 μg of misoprostol (Cytotec, Pfizer, G.D. Searle LLC) administered rectally via urinary catheter insertion preoperatively
Locations (1)
Cairo University
Cairo, Cairo Governorate, Egypt